Works matching DE "GLUCAGON-like peptide-1 agonists"
Results: 2588
Evolving Type 2 diabetes management focuses on clinical outcomes.
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 4, p. 165, doi. 10.1007/s40267-022-00903-z
- By:
- Publication type:
- Article
Obstetrician-Gynecologists' Strategies for Patient Initiation and Maintenance of Antiobesity Treatment with Glucagon-Like Peptide-1 Receptor Agonists.
- Published in:
- Journal of Women's Health (15409996), 2021, v. 30, n. 7, p. 1016, doi. 10.1089/jwh.2020.8683
- By:
- Publication type:
- Article
Addressing free fatty acid receptor 1 (FFAR1) activation using supervised molecular dynamics.
- Published in:
- Journal of Computer-Aided Molecular Design, 2020, v. 34, n. 11, p. 1181, doi. 10.1007/s10822-020-00338-6
- By:
- Publication type:
- Article
Glucagon-like Peptide-1 Receptor Agonists and Diabetic Osteopathy: Another Positive Effect of Incretines? A 12 Months Longitudinal Study.
- Published in:
- Calcified Tissue International, 2024, v. 115, n. 2, p. 160, doi. 10.1007/s00223-024-01240-1
- By:
- Publication type:
- Article
Narrative Review of Effects of Glucagon-Like Peptide-1 Receptor Agonists on Bone Health in People Living with Obesity.
- Published in:
- Calcified Tissue International, 2024, v. 114, n. 2, p. 86, doi. 10.1007/s00223-023-01150-8
- By:
- Publication type:
- Article
Bone Fracture Risk is Not Associated with the Use of Glucagon-Like Peptide-1 Receptor Agonists: A Population-Based Cohort Analysis.
- Published in:
- Calcified Tissue International, 2015, v. 97, n. 2, p. 104, doi. 10.1007/s00223-015-9993-5
- By:
- Publication type:
- Article
GLP 1 receptor agonists and obesity-associated cancers: a disproportionality analysis in Vigibase®.
- Published in:
- 2024
- By:
- Publication type:
- Letter
A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 5, p. 669, doi. 10.1007/s00228-024-03646-0
- By:
- Publication type:
- Article
Comparison of the efficacy and safety of hypoglycemic treatments in patients with non-alcoholic fatty liver disease and type-2 diabetes: a systematic review and Bayesian network analysis.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 11, p. 1465, doi. 10.1007/s00228-023-03561-w
- By:
- Publication type:
- Article
Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of increased evidence of their cardiovascular benefits (2014–2022).
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 9, p. 1239, doi. 10.1007/s00228-023-03539-8
- By:
- Publication type:
- Article
Association between glucagon-like peptide-1 receptor gene polymorphism and treatment response to GLP1R agonists in Chinese patients with type 2 diabetes: a prospective cohort study.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 5, p. 793, doi. 10.1007/s00228-021-03249-z
- By:
- Publication type:
- Article
Effect of GLP-1R rs2254336 and rs3765467 polymorphisms on gastrointestinal adverse reactions in type 2 diabetes patients treated with liraglutide.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 4, p. 589, doi. 10.1007/s00228-021-03225-7
- By:
- Publication type:
- Article
Drug-drug interactions and inappropriate medicines impact on glycemic control and kidney function in older adults with diabetes-attending specialty care institution.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 9, p. 1397, doi. 10.1007/s00228-021-03107-y
- By:
- Publication type:
- Article
Genetic variability in GLP-1 receptor is associated with inter-individual differences in weight lowering potential of liraglutide in obese women with PCOS: a pilot study.
- Published in:
- European Journal of Clinical Pharmacology, 2015, v. 71, n. 7, p. 817, doi. 10.1007/s00228-015-1868-1
- By:
- Publication type:
- Article
Use of exenatide and liraglutide in Denmark: a drug utilization study.
- Published in:
- European Journal of Clinical Pharmacology, 2014, v. 70, n. 2, p. 205, doi. 10.1007/s00228-013-1595-4
- By:
- Publication type:
- Article
A systematic review of GLP-1 agonists on the metabolic syndrome in women with polycystic ovaries.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Insights from a multicenter nationwide cohort analysis in Japan on the association of underlying conditions and pharmacological interventions with COVID-19 disease severity.
- Published in:
- Discover Public Health, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12982-024-00225-7
- By:
- Publication type:
- Article
Tirzepatide a novel anti diabetic molecule unfold dual action.
- Published in:
- Discover Public Health, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12982-024-00200-2
- By:
- Publication type:
- Article
Expanding the Obesity Treatment Toolbox: The Promise of Dual-Action Medications.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Metabolic Bariatric Surgery Takes a Backseat as GLP-1RA Use Rises: Daily Dose.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Metabolic Bariatric Surgery Takes a Backseat as GLP-1RA Use Soars, According to New Research: Clinicians should continue to monitor trade-offs between pharmacologic and surgical management of obesity, researchers said.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Survodutide Wins FDA Breakthrough Therapy Designation for Noncirrhotic MASH Treatment in Adults.
- Published in:
- Patient Care (Online), 2024, p. 6
- By:
- Publication type:
- Article
Roche Oral Incretin Mimetic CT-966 Moves to Phase 2 Clinical Development.
- Published in:
- Patient Care (Online), 2024, p. 74
- By:
- Publication type:
- Article
WHO Issues Medical Product Alert for Counterfeit Semaglutide.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Two Medication Classes Reduce CV, Liver Events in Persons with T2D, MASLD: Daily Dose.
- Published in:
- Patient Care (Online), 2024, p. 2
- Publication type:
- Article
GLP-1RAs Linked to Lower Risk for Cirrhosis in Patients with MASLD, Type 2 Diabetes: Daily Dose.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
GLP-1 Agonists Reduce Risk of Cirrhosis, HCC in Adults with MASLD and T2D.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Survodutide, Dual Glucagon/GLP-1 Mimetic, Improves MASH in 83% of Phase 2 Trial Participants.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
13 Drugs Approved for Primary Care in 2023.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Long-Term Effects of Incretin-Based Drugs on Glycemic Control in Permanent Neonatal Diabetes.
- Published in:
- JCEM Case Reports, 2024, v. 2, n. 11, p. 1, doi. 10.1210/jcemcr/luae188
- By:
- Publication type:
- Article
Euglycemic Ketoacidosis From Semaglutide in a Patient Without Diabetes.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Delayed Type Hypersensitivity Reaction Induced By Liraglutide With Tolerance to Semaglutide.
- Published in:
- JCEM Case Reports, 2024, v. 2, n. 6, p. 1, doi. 10.1210/jcemcr/luae105
- By:
- Publication type:
- Article
Semaglutide for Treating Obesity Induced by Craniopharyngioma Resection: A Successful Case Study.
- Published in:
- JCEM Case Reports, 2023, v. 1, n. 4, p. 1, doi. 10.1210/jcemcr/luad074
- By:
- Publication type:
- Article
Combined GLP-1 Receptor Agonist and Amylin Analogue Pharmacotherapy to Treat Obesity Comorbid With Type 1 Diabetes.
- Published in:
- JCEM Case Reports, 2023, v. 1, n. 2, p. 1, doi. 10.1210/jcemcr/luad040
- By:
- Publication type:
- Article
Effects of antidiabetic drugs on bone metabolism.
- Published in:
- Advances in Laboratory Medicine / Avances en Medicina de Laboratorio, 2024, v. 5, n. 1, p. 85, doi. 10.1515/almed-2024-0038
- By:
- Publication type:
- Article
Attitudes and knowledge about weight management among primary care physicians in Israel: a cross-sectional study.
- Published in:
- BMC Primary Care, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12875-024-02324-5
- By:
- Publication type:
- Article
A Review of GLP-1RAs & SGLT-2is in Type 2 Diabetes.
- Published in:
- Family Doctor: A Journal of the New York State Academy of Family Physicians, 2020, v. 9, n. 2, p. 10
- By:
- Publication type:
- Article
Short-term intervention with liraglutide improved eating behavior in obese women with polycystic ovary syndrome.
- Published in:
- Endocrine Research, 2015, v. 40, n. 3, p. 133, doi. 10.3109/07435800.2014.966385
- By:
- Publication type:
- Article
Comparative analysis of newer classes of antidiabetics and the concept of pharmaceutical care - dealing with therapeutic problems.
- Published in:
- Pharmacia (0428-0296), 2024, v. 71, n. 1, p. 1, doi. 10.3897/pharmacia.71.e120141
- By:
- Publication type:
- Article
Pharmacogenetics of Glucagon-like-peptide-1 receptor in diabetes management.
- Published in:
- Pharmacia (0428-0296), 2023, v. 70, n. 2, p. 383, doi. 10.3897/pharmacia.70.e104481
- By:
- Publication type:
- Article
Preventing diabetic kidney disease progression: An update.
- Published in:
- Medicine Today, 2023, v. 24, n. 11, p. 29
- By:
- Publication type:
- Article
Preventing diabetic kidney disease progression: An update.
- Published in:
- Medicine Today, 2023, v. 24, n. 8, p. 15
- By:
- Publication type:
- Article
Medicare Should Cover Weight Loss Drugs as Long as the Prices are Affordable.
- Published in:
- Journal of Law, Medicine & Ethics, 2024, v. 52, n. 1, p. 188, doi. 10.1017/jme.2024.56
- By:
- Publication type:
- Article
Glucagon-like peptide-1 receptor agonists in patients treated with antipsychotics.
- Published in:
- European Psychiatry, 2021, v. 64, p. S775, doi. 10.1192/j.eurpsy.2021.2050
- By:
- Publication type:
- Article
Asthma Exacerbations and Glucagon-Like Peptide-1 Receptor Agonists: a Review of the Current Evidence.
- Published in:
- Pulmonary Therapy, 2022, v. 8, n. 4, p. 343, doi. 10.1007/s41030-022-00203-x
- By:
- Publication type:
- Article
A CLINICAL CASE OF ASYMPTOMATIC PANCREATIC HYPERENZYMEMIA ON THE BACKGROUND OF TAKING A GLUCAGON-LIKE PEPTIDE-1 ANALOGUE (GLP-1).
- Published in:
- Medical Perspectives / Medičnì Perspektivi, 2023, v. 28, n. 3, p. 213, doi. 10.26641/2307-0404.2023.3.289229
- By:
- Publication type:
- Article
Is polyethylene glycol loxenatide 100 μg the preferred glucagon-like peptide-1 receptor agonist for type 2 diabetes mellitus? A meta-analysis and trial sequential analysis.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2024, v. 28, n. 6, p. 2272
- By:
- Publication type:
- Article
Oxidative stress and inflammation in COVID-19: potential application OF GLP-1 receptor agonists.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2023, v. 27, n. 13, p. 6459
- By:
- Publication type:
- Article
Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer's disease.
- Published in:
- Acta Neuropathologica Communications, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40478-021-01180-z
- By:
- Publication type:
- Article
Fasting plasma c-peptide level predicts the response of glucagon-like peptide-1 agonist (exenatide) add on to metformin monotherapy in obese type 2 diabetics.
- Published in:
- Journal of Experimental & Clinical Medicine / Deneysel ve Klinik Tip Dergisi, 2022, v. 39, n. 3, p. 798, doi. 10.52142/omujecm.39.3.39
- By:
- Publication type:
- Article